Yoseph Shaaltiel
2011
In 2011, Yoseph Shaaltiel earned a total compensation of $413.2K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 23% decrease compared to previous year.
Compensation breakdown
| Option Awards | $27,830 |
|---|---|
| Salary | $305,280 |
| Other | $80,063 |
| Total | $413,173 |
Shaaltiel received $305.3K in salary, accounting for 74% of the total pay in 2011.
Shaaltiel also received $27.8K in option awards and $80.1K in other compensation.
Rankings
In 2011, Yoseph Shaaltiel's compensation ranked 8,582nd out of 10,747 executives tracked by ExecPay. In other words, Shaaltiel earned more than 20.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,582 out of 10,747 | 20th |
Division Manufacturing | 3,184 out of 3,960 | 20th |
Major group Chemicals And Allied Products | 793 out of 1,033 | 23rd |
Industry group Drugs | 580 out of 781 | 26th |
Industry Biological Products, Except Diagnostic Substances | 99 out of 157 | 37th |
Source: SEC filing on October 9, 2014.
Shaaltiel's colleagues
We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2011.